[go: up one dir, main page]

TR201005911A2 - A drug formulation with improved dissolution profile. - Google Patents

A drug formulation with improved dissolution profile.

Info

Publication number
TR201005911A2
TR201005911A2 TR2010/05911A TR201005911A TR201005911A2 TR 201005911 A2 TR201005911 A2 TR 201005911A2 TR 2010/05911 A TR2010/05911 A TR 2010/05911A TR 201005911 A TR201005911 A TR 201005911A TR 201005911 A2 TR201005911 A2 TR 201005911A2
Authority
TR
Turkey
Prior art keywords
drug formulation
dissolution profile
improved dissolution
dexketoprofen
improved
Prior art date
Application number
TR2010/05911A
Other languages
Turkish (tr)
Inventor
Uslu Abdullah
Ünlü Serdar
Fethi̇ Şahi̇n M.
Kabaş Zi̇ya
Sert Ridvan
Firinci Eli̇f
Original Assignee
Fargem Farmasöti̇k Araştirma Geli̇şti̇rme Merkezi̇ Sanayi̇ Ve Ti̇caret A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fargem Farmasöti̇k Araştirma Geli̇şti̇rme Merkezi̇ Sanayi̇ Ve Ti̇caret A.Ş. filed Critical Fargem Farmasöti̇k Araştirma Geli̇şti̇rme Merkezi̇ Sanayi̇ Ve Ti̇caret A.Ş.
Priority to TR2010/05911A priority Critical patent/TR201005911A2/en
Publication of TR201005911A2 publication Critical patent/TR201005911A2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu buluş, deksketoprofen veya deksketoprofen'in farmasötik açıdan kabul edilebilir bir tuzunu etkin madde olarak içeren tablet formundaki farmasötik formülasyon ile ilgilidir.The present invention relates to a pharmaceutical formulation in tablet form comprising dexketoprofen or a pharmaceutically acceptable salt of dexketoprofen as an active ingredient.

TR2010/05911A 2010-07-20 2010-07-20 A drug formulation with improved dissolution profile. TR201005911A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2010/05911A TR201005911A2 (en) 2010-07-20 2010-07-20 A drug formulation with improved dissolution profile.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/05911A TR201005911A2 (en) 2010-07-20 2010-07-20 A drug formulation with improved dissolution profile.

Publications (1)

Publication Number Publication Date
TR201005911A2 true TR201005911A2 (en) 2012-02-21

Family

ID=47666931

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/05911A TR201005911A2 (en) 2010-07-20 2010-07-20 A drug formulation with improved dissolution profile.

Country Status (1)

Country Link
TR (1) TR201005911A2 (en)

Similar Documents

Publication Publication Date Title
TN2012000371A1 (en) Pyrazole compounds as crth2 antagonists
MX369121B (en) Aqueous pharmaceutical formulation of tapentadol for oral administration.
SG194756A1 (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
EA201071204A1 (en) DRONEDARON APPLICATION FOR THE PREPARATION OF A MEDICINE FOR THE APPLICATION IN THE PREVENTION OF HOSPITALIZATION IN THE CARDIOLOGICAL DEPARTMENT OR MORTALITY
PH12016500420A1 (en) Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt
EA201690679A1 (en) STABLE PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPIPIN AND VALSARTAN
CY1115556T1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION THAT INCLUDES DAVIGATRAN
PH12014502366A1 (en) Injectable formulation
MX344846B (en) COMBINATION OF ACTIVE LOADED GRANULES WITH ADDITIONAL ASSETS.
MX347105B (en) Pharmaceutical compositions comprising hydromorphone and naloxone.
EA201300857A1 (en) PYRAZOLES AS AN ANTAGONISTS CRTH2
MX363389B (en) Pharmaceutical composition comprising amorphous ivabradine.
TR201001417A1 (en) Cefdinir formulation with improved dissolution rate
EP2871187A4 (en) Novel compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient
TR201815617A2 (en) A formulation containing dexketoprofen.
TR201007926A1 (en) Prasugrel tablet formulations.
EA201590732A1 (en) DISPENSABLE TABLET
TR201005911A2 (en) A drug formulation with improved dissolution profile.
IN2012CH05549A (en)
TR201009399A2 (en) Rapidly soluble effervescent rosuvastatin formulations.
EP2842938A4 (en) NOVEL BETA-ALANINE DERIVATIVES, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS ACTIVE INGREDIENT
NZ702849A (en) Genotype- or phenotype-based drug formulation
WO2013072770A3 (en) Pharmaceutical formulations comprising atorvastatin and glimepiride
WO2012153347A3 (en) Oral pharmaceutical composition of olanzapine form 1 and sodium starch glycolate
EA201491477A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING FLUPIRTIN